Horn Howard
Transaction: 08/03/2026
SELL
Change
-4,696
Price
$24.92
Filing
08/04/2026
Type
SELL
Ultragenyx Pharmaceutical Inc.
RARE • Biotechnology
$15.30
▲ +0.45 (+3.03%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.56B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 7.1%Healthy liquidity · 2.48Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:56 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$15.30
Change3.03%
Shares Out101.90M
Market Cap$1.56B
Enterprise Value$1.27B
52W Range18.29 - 39.89
Beta0.31
P/E-2.66
P/S2.17
P/B-5.49
P/FCF-3.19
EV/Sales1.77
Price$15.30
Change3.03%
Shares Out101.90M
Market Cap$1.56B
Enterprise Value$1.27B
52W Range18.29 - 39.89
Beta0.31
P/E-2.66
P/S2.17
P/B-5.49
P/FCF-3.19
EV/Sales1.77
EV/EBITDA-2.54
EV/FCF-2.59
Earnings Yield-37.61%
FCF Yield-31.39%
Dividend Yield0.00%
Gross Margin83.80%
Oper. Margin-79.49%
Profit Margin-85.44%
Debt/Eq-15.95
Current Ratio2.48
Quick Ratio2.34
Target$27.69
Target Upside80.98%
Target Median$25.00
Target Range16.00 - 60.00
Volume1.84M
Avg Volume2.14M
EPS Surprise-0.35
Investment DNA
How strong this company looks for long-term investors
49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
81/100
Price Attractiveness
Cheap or expensive today
75/100
Why this score▼
Positive revenue growth · 7.1%Healthy liquidity · 2.48Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 33 analyst votes · 2026-09-05
88/100
Bullish
Bullish
26
Hold
6
Bearish
1
Price Target
2026-08-07
Low
$30.00
Mean
$46.00
Median
$41.50
High
$67.00
Insider Transactions
Recent executive and insider activity
Parschauer Karah Herdman
Transaction: 08/03/2026
SELL
Change
-1,900
Price
$24.92
Filing
08/04/2026
Type
SELL
Horn Howard
Transaction: 07/01/2026
SELL
Change
-4,698
Price
$33.13
Filing
07/06/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Horn Howard | SELL | -4,696 | $24.92 | 08/03/2026 | 08/04/2026 |
| Parschauer Karah Herdman | SELL | -1,900 | $24.92 | 08/03/2026 | 08/04/2026 |
| Horn Howard | SELL | -4,698 | $33.13 | 07/01/2026 | 07/06/2026 |
| Parschauer Karah Herdman | SELL | -1,899 | $24.62 | 06/15/2026 | 06/15/2026 |
| Sanders Corazon (Corsee) D. | SELL | -2,000 | $25.05 | 06/15/2026 | 06/15/2026 |
| Horn Howard | SELL | -4,653 | $23.77 | 06/01/2026 | 06/01/2026 |
| SULIMAN SHEHNAAZ | SELL | -5,740 | $25.12 | 05/18/2026 | 05/18/2026 |
| Dunsire Deborah | BUY | +14,058 | $25.80 | 05/14/2026 | 05/18/2026 |
| Dunsire Deborah | BUY | +7,751 | Not reported | 05/14/2026 | 05/18/2026 |
| WELCH DANIEL G | BUY | +14,058 | $25.80 | 05/14/2026 | 05/18/2026 |
| WELCH DANIEL G | BUY | +7,751 | Not reported | 05/14/2026 | 05/18/2026 |
| NARACHI MICHAEL | BUY | +14,058 | $25.80 | 05/14/2026 | 05/18/2026 |
| NARACHI MICHAEL | BUY | +7,751 | Not reported | 05/14/2026 | 05/18/2026 |
| Sanders Corazon (Corsee) D. | BUY | +14,058 | $25.80 | 05/14/2026 | 05/18/2026 |
| Sanders Corazon (Corsee) D. | BUY | +7,751 | Not reported | 05/14/2026 | 05/18/2026 |
| Ray Amrit | BUY | +14,058 | $25.80 | 05/14/2026 | 05/18/2026 |
| Ray Amrit | BUY | +7,751 | Not reported | 05/14/2026 | 05/18/2026 |
| SULIMAN SHEHNAAZ | BUY | +14,058 | $25.80 | 05/14/2026 | 05/18/2026 |
| SULIMAN SHEHNAAZ | BUY | +7,751 | Not reported | 05/14/2026 | 05/18/2026 |
| Fust Matthew K | BUY | +14,058 | $25.80 | 05/14/2026 | 05/18/2026 |